Search Results - "Ahmed Naqvi, Syed Arsalan"

S855 Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Endoscopy Outcomes: A Systematic Review and Meta-Analysis by Tariq, Raseen, Ahmed Naqvi, Syed Arsalan, Prokop, Larry J., Pardi, Darrell S., Khanna, Sahil

Get full text

S1187 Fecal Microbiota Transplantation and Clinical Outcomes Among Inflammatory Bowel Disease Patients: An Umbrella Review by Malik, Sheza, Ahmed Naqvi, Syed Arsalan, Loftus, William, Renisha, Redij, Tariq, Raseen, Khanna, Sahil

Get full text

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma by Riaz, Irbaz Bin, He, Huan, Ryu, Alexander J., Siddiqi, Rabbia, Naqvi, Syed Arsalan Ahmed, Yao, Yuan, Husnain, Muhammad, Narasimhulu, Deepa Maheswari, Mathew, Jessey, Sipra, Qurat Ul Ain Riaz, Vandvik, Per Olav, Joseph, Richard W., Liu, Hongfang, Wang, Zhen, Herasevich, Vitaly, Singh, Parminder, Hussain, Syed A., Ho, Thai H., Bryce, Alan H., Pagliaro, Lance C., Murad, Mohammad H., Costello, Brian A.

“…Identifying the most effective first-line treatment for metastatic renal cell carcinoma (mRCC) is challenging as rapidly evolving data quickly outdate the…”
Get full text

Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis by Bilal, Jawad, Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, Bhattacharjee, Sandipan, Obert, Michelle R., Sadiq, Maryam, Abd El Aziz, Mohamed A., Nomaan, Yahya, Prokop, Lary J., Ge, Long, Murad, Mohammad H., Bryce, Alan H., McBane, Robert D., Kwoh, C. Kent

“…To assess the risk of venous thromboembolism (VTE) in patients treated with Janus kinase (JAK) inhibitors in clinical trials. We performed a literature search…”
Get full text

Water contamination: A grave health hazard by Ahmed Naqvi, Syed Arsalan, Haider, Mohammad Zeeshan

Get full text

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis by Riaz, Irbaz Bin, Fuentes, Harry, Deng, Yihong, Naqvi, Syed Arsalan Ahmed, Yao, Xiaoxi, Sangaralingham, Lindsey R, Houghton, Damon E, Padrnos, Leslie J, Shamoun, Fadi E, Wysokinski, Waldemar E, McBane, 2nd, Robert D

“…Patterns of clinical utilization and comparative effectiveness of anticoagulants for cancer-associated thrombosis (CAT) remain largely unexplored. To assess…”
Get full text

Future of Evidence Synthesis: Automated, Living, and Interactive Systematic Reviews and Meta-analyses by Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, Hasan, Bashar, Murad, Mohammad Hassan

Get full text

The Emerging Discipline of Cardio-Oncology; What, why and how? by Ahmed Naqvi, Syed Arsalan, Hasan Zaidi, Syed Danish, Haider, Mohammad Zeeshan

Get full text

Natural Coronary Bypass: A Rare Case of Aortocoronary Fistula in a Patient with Three-Vessel Disease by Naqvi, Syed Arsalan Ahmed, Zaidi, Syed Danish, Gul, Owais, Dar, Mudassir Iqbal, Aziz, Abdul

“…Coronary arterial fistula (CAF) is an abnormal connection between one or both coronary arteries and a cardiac/extra-cardiac chamber or another vessel…”
Get full text

Caffeine Consumption and Academic Performance among Medical Students of Dow University of Health Science (DUHS), Karachi, Pakistan by Muhammad Sami Khan, Nighat Nisar, Syed Arsalan Ahmed Naqvi

“…Objective: To determine the frequency of caffeine consumption and  its  effect  on  academic  perfor-  mance among medical students of DUHS, Karachi, Pakistan…”
Get full text

Thyroid and Heart: Severe Three Vessel Coronary Artery Disease in a Middle-Aged Female with Hypothyroidism by Muneer, Ramsha, Naqvi, Syed Arsalan Ahmed, Gul, Owais, Zaidi, Syed Danish H, Dar, Mudassir Iqbal

“…Hypothyroidism is a common medical condition. The low metabolic state in hypothyroidism leads to significant cardiovascular and hemodynamic changes…”
Get full text

Assessment of Clinicians’ Satisfaction With Laboratories at a Public Sector Hospital in Karachi, Pakistan by Naqvi, Syed Arsalan Ahmed, Hameed, Aimel, Tanveer, Yusra, Memon, Zahid Ali, Masood, Rida

“…ObjectiveThe goal of this study was to assess the level of satisfaction of clinicians regarding the provision of information, accessibility, and services by…”
Get full text

Predictors of symptom scores in myeloproliferative neoplasms: A real-world retrospective cohort study by Khan, Muhammad Ali, Naqvi, Syed Arsalan Ahmed, Riaz, Irbaz Bin, Palmer, Jeanne M.

“…6582 Background: Although high symptom burden indicates poor survival and informs treatment decisions, little is known about the impact of demographic,…”
Get full text

Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience by Ballouz, Tara, Tripathi, Nikita, Naqvi, Syed Arsalan Ahmed, Saxena, Akshat, Bibi, Arifa, Kase, Adam McLain, Childs, Daniel S, Orme, Jacob, Bryce, Alan Haruo, Riaz, Irbaz Bin, Singh, Parminder

“…627 Background: Enfortumab vedotin (EV) is an antibody-drug conjugate recently approved to treat locally advanced or metastatic bladder cancer (la/mUC)…”
Get full text

Clinical efficacy of enfortumab-pembrolizumab combination therapy in locally advanced/metastatic urothelial carcinoma (UC): A real-world experience by Tripathi, Nikita, Naqvi, Syed Arsalan Ahmed, Ballouz, Tara, Saxena, Akshat, Bibi, Arifa, Khan, Muhammad Ali, Channar, Aneeta, Riaz, Irbaz Bin, Tyson, Mark, Bryce, Alan Haruo, Singh, Parminder

“…643 Background: The FDA approval of enfortumab (EV) and pembrolizumab (Pembro) combination therapy as a first-line treatment for cisplatin-ineligible patients…”
Get full text

A meta-analysis assessing objective response rates with first-line systemic treatment options in locally advanced/metastatic urothelial carcinoma by Saxena, Akshat, Naqvi, Syed Arsalan Ahmed, Tripathi, Nikita, Khan, Muhammad Ali, Bibi, Arifa, Ballouz, Tara, Abdul-Muhsin, Haidar, Tyson, Mark, Riaz, Irbaz Bin, Bryce, Alan Haruo, Singh, Parminder

“…639 Background: Immunotherapy combined with chemotherapy (IO/C) as the first-line management of locally advanced or metastatic urothelial carcinoma (LA/mUC)…”
Get full text

Clinical efficacy of lurbinectedin in metastatic neuroendocrine carcinomas of the genitourinary tract: Multi-institutional real-world experience by Moussa, Mohammad Jad, Naqvi, Syed Arsalan Ahmed, Khandelwal, Jaanki, Campbell, Matthew T, Aparicio, Ana, Siddiqui, Bilal Ahmed, Bryce, Alan Haruo, Singh, Parminder, Alhalabi, Omar

“…601 Background: Neuroendocrine carcinomas (NEC) of the genitourinary (GU) tract, including small cell (SC) NEC and large cell (LC) NEC, are rare aggressive…”
Get full text

Anti-CD19 chimeric antigenic receptor T cell as a second-line therapy for patients with relapsed/refractory diffuse large B-cell lymphoma by Naqvi, Syed Arsalan Ahmed, Asghar, Noureen, Sipra, Qurat Ul Ain Riaz, Paludo, Jonas, Riaz, Irbaz Bin, Husnain, Muhammad

“…e19502 Background: Inconsistent results observed in recent trials (ZUMA-7, TRANSFORM, BELINDA) assessing chimeric antigenic receptor T (CAR-T) cell therapy in…”
Get full text

Incidence of second primary malignancies (SPMs) in patients with multiple myeloma (MM) receiving anti-CD38 monoclonal antibodies (mAbs): A systematic review and meta-analysis by Mian, Agrima, Naqvi, Syed Arsalan Ahmed, Ayaz, Ahsan, Husnain, Muhammad, Aljama, Mohammed A., Mohyuddin, Ghulam Reham, Koehn, Kelly, Mohan, Meera, Riaz, Irbaz Bin, Chakraborty, Rajshekhar

“…e24078 Background: The addition of anti-CD38 mAbs, daratumumab and isatuximab, to standard anti-myeloma regimens have drawn scrutiny towards long-term safety…”
Get full text

The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis by Naqvi, Syed Arsalan Ahmed, Riaz, Irbaz Bin, He, Huan, Imran, Manal, Orme, Jacob, Childs, Daniel S, Ravi, Praful, Hussain, Syed A., Singh, Parminder, Bryce, Alan Haruo

“…5088 Background: Previous evidence suggests that there may be no additional benefit of triplet therapy in low volume disease based on limited data. Therefore,…”
Get full text